A citation-based method for searching scientific literature

Elli Papaemmanuil, Moritz Gerstung, Lars Bullinger, Verena I Gaidzik, Peter Paschka, Nicola D Roberts, Nicola E Potter, Michael Heuser, Felicitas Thol, Niccolo Bolli, Gunes Gundem, Peter Van Loo, Inigo Martincorena, Peter Ganly, Laura Mudie, Stuart McLaren, Sarah O'Meara, Keiran Raine, David R Jones, Jon W Teague, Adam P Butler, Mel F Greaves, Arnold Ganser, Konstanze Döhner, Richard F Schlenk, Hartmut Döhner, Peter J Campbell. N Engl J Med 2016
Times Cited: 1591



Courtney D DiNardo, Brian A Jonas, Vinod Pullarkat, Michael J Thirman, Jacqueline S Garcia, Andrew H Wei, Marina Konopleva, Hartmut Döhner, Anthony Letai, Pierre Fenaux, Elizabeth Koller, Violaine Havelange, Brian Leber, Jordi Esteve, Jianxiang Wang, Vlatko Pejsa, Roman Hájek, Kimmo Porkka, Árpád Illés, David Lavie, Roberto M Lemoli, Kazuhito Yamamoto, Sung-Soo Yoon, Jun-Ho Jang, Su-Peng Yeh, Mehmet Turgut, Wan-Jen Hong, Ying Zhou, Jalaja Potluri, Keith W Pratz. N Engl J Med 2020
Times Cited: 227




List of shared articles



Times cited


Acute myeloid leukemia: current progress and future directions.
Hagop Kantarjian, Tapan Kadia, Courtney DiNardo, Naval Daver, Gautam Borthakur, Elias Jabbour, Guillermo Garcia-Manero, Marina Konopleva, Farhad Ravandi. Blood Cancer J 2021
10

TP53 Mutations in Acute Myeloid Leukemia: Still a Daunting Challenge?
Matteo Molica, Carla Mazzone, Pasquale Niscola, Paolo de Fabritiis. Front Oncol 2021
2

Novel Targeted Therapeutics in Acute Myeloid Leukemia: an Embarrassment of Riches.
Nicole R Grieselhuber, Alice S Mims. Curr Hematol Malig Rep 2021
0

Genetic alterations in Thai adult patients with acute myeloid leukemia and myelodysplastic syndrome-excess blasts detected by next-generation sequencing technique.
Weerapat Owattanapanich, Julia Herzig, Nikolaus Jahn, Ekaterina Panina, Theera Ruchutrakool, Smith Kungwankiattichai, Surapol Issaragrisil, Hartmut Döhner, Konstanze Döhner. Ann Hematol 2021
0

Novel agents and regimens for hematological malignancies: recent updates from 2020 ASH annual meeting.
Jing-Zhou Hou, Jing Christine Ye, Jeffrey J Pu, Hongtao Liu, Wei Ding, Hong Zheng, Delong Liu. J Hematol Oncol 2021
1

Diagnostic and therapeutic pitfalls in NPM1-mutated AML: notes from the field.
Brunangelo Falini, Sofia Sciabolacci, Lorenza Falini, Lorenzo Brunetti, Maria Paola Martelli. Leukemia 2021
0

Impact of splicing mutations in acute myeloid leukemia treated with hypomethylating agents combined with venetoclax.
Curtis A Lachowiez, Sanam Loghavi, Ken Furudate, Guillermo Montalban-Bravo, Abhishek Maiti, Tapan Kadia, Naval Daver, Gautam Borthakur, Naveen Pemmaraju, Koji Sasaki,[...]. Blood Adv 2021
1

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia.
Claudio Cerchione, Alessandra Romano, Naval Daver, Courtney DiNardo, Elias Joseph Jabbour, Marina Konopleva, Farhad Ravandi-Kashani, Tapan Kadia, Maria Paola Martelli, Alessandro Isidori,[...]. Front Oncol 2021
0

Optimizing Risk Stratification in Acute Myeloid Leukemia: Dynamic Models for a Dynamic Therapeutic Landscape.
Nicholas J Short, Martin S Tallman, Daniel A Pollyea, Farhad Ravandi, Hagop Kantarjian. J Clin Oncol 2021
1

Mitochondrial metabolism: powering new directions in acute myeloid leukemia.
Ryan J Stubbins, Irina A Maksakova, David S Sanford, Arefeh Rouhi, Florian Kuchenbauer. Leuk Lymphoma 2021
0

Acute myeloid leukemia with IDH1 and IDH2 mutations: 2021 treatment algorithm.
Ghayas C Issa, Courtney D DiNardo. Blood Cancer J 2021
0


Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML.
Yuki Nishida, Ran Zhao, Lauren E Heese, Hiroki Akiyama, Shreya Patel, Alex M Jaeger, Rodrigo O Jacamo, Kensuke Kojima, Man Chun John Ma, Vivian R Ruvolo,[...]. Leukemia 2021
0